Latest Investment Funds biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

The University promotes an incubator to foster entrepreneurship in the field of biosanitation

by Universidad de Navarra

1 year ago
biosanitary sector, incubator specialized in healt

The incubator, whose goal is to transfer knowledge and apply its clinical and research and development capabilities to the market through startups, is working on the feasibility of 8 new projects.

Asabys announces the first close of its fund, with commitments of €100M

by Asabys Partners

1 year ago
Asabys

Asabys has announced the 1st closing of its 2nd fund, with commitments of €100 million. The firm’s goal is to reach €200 million this year, to invest in 12 to 15 companies in the EU, Israel, UK ...

Negotiating a Round in the health sector (Part 2) The roadshow and the negotiation of the deal

by GENESIS Biomed

1 year ago
pre-money valuation, equity, roadshow

This article with the most representative slides to start the roadshow, will allow us to face with guarantees the success of the journey we will undertake in the negotiation of our investment round wi...

Sabadell Asabys invests in DeepUll extending its Series B to €17M

by Asabys Partners

1 year ago
DeepUll, Asabys Partners, Sabadell Asabys Healthcare Innovation Investments II

Asabys announces today the first investment of its new fund, SAHII II (Sabadell Asabys Healthcare Innovation Investments II), launched with the support of Banco Sabadell, in DeepUll, a Barcelona-based...

The 2023 Strategic Action in Health of the ISCIII allocates 144 million for aid to biomedical and health research contracts and projects

by Instituto de Investigación Biosanitaria - Ibs Granada

1 year ago
Strategic Health Action (AES)

The Strategic Health Action (AES), which is managed by the Carlos III Health Institute (ISCIII) as a body under the Ministry of Science and Innovation, is the main annual tool for financing biomedical...

VarmX raises €30 million Series B2 financing for IND approval and preparations for pivotal trial

by Ysios Capital

11 months ago
VMX-C001, anticoagulants, VarmX

VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces it has successfully raised an additional €30 million in a Series B2...

MiMARK Diagnostics capta 1 M€ para acelerar el desarrollo de su test de diagnóstico in vitro para cáncer de endometrio

by Parc Científic de Barcelona

11 months ago
fluidos ginecológicos, cáncer de endometrio WomEC, MiMARK Diagnostics

Esta inversión marca el inicio de una nueva etapa para la compañía, con nuevos retos y desafíos, y acompaña en el camino para conseguir el objetivo; mejorar el diagnóstico en ginecología convir...

CorWave Announces Second Closing of Its Series C Funding at €61M To Finance Its First Industrial Deployment

by Ysios Capital

10 months ago
CorWave

CorWave raised 61 million euros to fund its first industrial deployment and entry into clinical trials. SPI fund, managed by Bpifrance on behalf of the French Government as part of France 2030, and le...

The artificial placenta project achieves foetal survival of 12 days in good health

by Fundació Clínic per a la Recerca Biomèdica

10 months ago
Artificial Placenta

The CaixaResearch Artificial Placenta project, led by BCNatal (Hospital Clínic Barcelona - SJD Barcelona Children's Hospital), is the first experimental project on artificial placenta with animal mod...

Tagworks Pharmaceuticals Announces $65 Million in Series A Financing led by Ysios Capital and Gilde Healthcare, to Advance Click-to-Release Therapeutics

by Ysios Capital

10 months ago
TGW101, Tagworks Pharmaceuticals, Ysios Capital, cancer cell

Tagworks Pharmaceuticals BV (“Tagworks”), the pioneer of Click-to-Release chemistry designed to deliver more effective and safer systemic therapies, today announced a $65 million Series A financin...

OneChain Immunotherapeutics secures €6.7M in pre-series A funding round led by Invivo Capital

by OneChain Immunotherapeutics

10 months ago
CAR-T therapies, OneChain Immunotherapeutics

OneChain Immunotherapeutics (OCI), a clinical stage biotech company focused on the development of CAR-T candidates for the treatment of oncological diseases, today announced the closing of a €6.7 mi...

IDP Pharma starts clinical trials of its first-in-class IDP-121 drug in hematological cancers and opens a financing round of €1M for the first phase of the study

by Parc Científic de Barcelona

10 months ago
IDP Pharma, IDP-121, multiple myeloma

The Spanish Agency of Medicines and Medical Devices has authorised the clinical trial of IDP-121, the first drug blocking and degrading a key oncoprotein in several hematological tumors, including mul...